Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure

BACKGROUND: Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Med
Hlavní autoři: Bhatia, Vikas, Bajaj, Navkaranbir S., Sanam, Kumar, Hashim, Taimoor, Morgan, Charity J., Prabhu, Sumanth D., Fonarow, Gregg C., Deedwania, Prakash, Butler, Javed, Carson, Peter, Love, Thomas E., Kheirbek, Raya, Aronow, Wilbert S., Anker, Stefan D., Waagstein, Finn, Fletcher, Ross, Allman, Richard M., Ahmed, Ali
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756434/
https://ncbi.nlm.nih.gov/pubmed/25554369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2014.11.036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky